October 30, 2012Acquires stake in Vital River
October 29, 2012Expands softgel business
October 29, 2012Enhances over-encapsulation speed and flexibility
October 26, 2012AnGes gains rights to Collategene in the U.S.
October 26, 2012Adds three new Asia-Pac facilities
October 24, 2012Will provide process development, manufacture at Australian Facility
October 24, 2012Will manufacture protein for malaria vaccine
October 23, 2012Will produce Placental eXpanded (PLX) cells
October 23, 2012Supports discovery of antiviral agents for dengue fever
Gil Roth||October 22, 2012Offers $36 mil. for Dutch service provider
Gil Roth||October 22, 2012Picks up portfolio, new ADHD treatment
October 19, 2012Gains rights to cold sore product in Canada
October 19, 2012Five-year supply agreement covers undisclosed product
October 18, 2012Expands vaccine portfolio
Gil Roth||October 17, 2012Will involve industry, academy, customers and regulators to advance delivery innovation
Sign up now to receive the free weekly newsletter, and more!
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.